Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.19 USD | +2.24% | -8.86% | +12.32% |
05-09 | Transcript : DiaMedica Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024 | |
04-17 | DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.32% | 121M | |
+5.66% | 111B | |
+11.23% | 105B | |
-12.15% | 22.34B | |
-2.91% | 21.93B | |
-6.03% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- DMAC Stock
- News DiaMedica Therapeutics Inc.
- Oppenheimer Upgrades DiaMedica Therapeutics to Outperform From Perform, $7 Price Target